Nature Medicine
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial
Randomised trial in 284 peopleType 2 diabetes
Papers by Xinhua Xiao
4 results
- Diabetes, Metabolic Syndrome and Obesity
Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials
Meta-analysis of randomised trialsInterventions - Diabetes, Metabolic Syndrome and Obesity
Serum GDF3 is Associated with Visceral Obesity, Insulin Resistance, and Inflammation in Non-Diabetic Adults: A Cross-Sectional Study with an Interventional Component
Cross-sectional study of 282 peopleInsulin resistance - ADA Scientific Sessions 2026 Abstract
Miglitol Ameliorates the Progression of High-Fat Diet–Induced Metabolic Dysfunction–Associated Steatotic Liver Disease in Mice by Inhibiting Ferroptosis
Experiments in animalsInterventions